122 related articles for article (PubMed ID: 8719241)
21. Flavin analogs with antimalarial activity as glutathione reductase inhibitors.
Becker K; Christopherson RI; Cowden WB; Hunt NH; Schirmer RH
Biochem Pharmacol; 1990 Jan; 39(1):59-65. PubMed ID: 2404494
[TBL] [Abstract][Full Text] [Related]
22. cDNA cloning of a novel cysteine protease of Plasmodium falciparum.
Hanspal M
Biochim Biophys Acta; 2000 Sep; 1493(1-2):242-5. PubMed ID: 10978531
[TBL] [Abstract][Full Text] [Related]
23. A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum.
Berry C; Humphreys MJ; Matharu P; Granger R; Horrocks P; Moon RP; Certa U; Ridley RG; Bur D; Kay J
FEBS Lett; 1999 Mar; 447(2-3):149-54. PubMed ID: 10214936
[TBL] [Abstract][Full Text] [Related]
24. Solubilizing buried domains of proteins: a self-assembling interface domain from glutathione reductase.
Leistler B; Perham RN
Biochemistry; 1994 Mar; 33(10):2773-81. PubMed ID: 8130189
[TBL] [Abstract][Full Text] [Related]
25. A cytidine triphosphate synthetase gene in Plasmodium falciparum.
Hendriks EF; O'Sullivan WJ; Stewart TS
Int J Parasitol; 1994 May; 24(3):397-9. PubMed ID: 8070957
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin networks in the malarial parasite Plasmodium falciparum.
Nickel C; Rahlfs S; Deponte M; Koncarevic S; Becker K
Antioxid Redox Signal; 2006; 8(7-8):1227-39. PubMed ID: 16910770
[TBL] [Abstract][Full Text] [Related]
27. Ferredoxin-NADP+ reductase from Plasmodium falciparum undergoes NADP+-dependent dimerization and inactivation: functional and crystallographic analysis.
Milani M; Balconi E; Aliverti A; Mastrangelo E; Seeber F; Bolognesi M; Zanetti G
J Mol Biol; 2007 Mar; 367(2):501-13. PubMed ID: 17258767
[TBL] [Abstract][Full Text] [Related]
28. COS cell expression cloning of Pfg377, a Plasmodium falciparum gametocyte antigen associated with osmiophilic bodies.
Alano P; Read D; Bruce M; Aikawa M; Kaido T; Tegoshi T; Bhatti S; Smith DK; Luo C; Hansra S; Carter R; Elliott JF
Mol Biochem Parasitol; 1995 Nov; 74(2):143-56. PubMed ID: 8719156
[TBL] [Abstract][Full Text] [Related]
29. The gene encoding topoisomerase I from the human malaria parasite Plasmodium falciparum.
Tosh K; Kilbey B
Gene; 1995 Sep; 163(1):151-4. PubMed ID: 7557466
[TBL] [Abstract][Full Text] [Related]
30. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy.
Rubin H; Salem JS; Li LS; Yang FD; Mama S; Wang ZM; Fisher A; Hamann CS; Cooperman BS
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9280-4. PubMed ID: 8415692
[TBL] [Abstract][Full Text] [Related]
31. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.
Brooks DR; Wang P; Read M; Watkins WM; Sims PF; Hyde JE
Eur J Biochem; 1994 Sep; 224(2):397-405. PubMed ID: 7925353
[TBL] [Abstract][Full Text] [Related]
32. Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry.
Burkard L; Scheuermann A; Simithy J; Calderón AI
Biomed Chromatogr; 2016 Apr; 30(4):543-7. PubMed ID: 26257195
[TBL] [Abstract][Full Text] [Related]
33. Thioredoxin and glutathione systems in Plasmodium falciparum.
Jortzik E; Becker K
Int J Med Microbiol; 2012 Oct; 302(4-5):187-94. PubMed ID: 22939033
[TBL] [Abstract][Full Text] [Related]
34. Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase.
Angelucci F; Miele AE; Boumis G; Dimastrogiovanni D; Brunori M; Bellelli A
Proteins; 2008 Aug; 72(3):936-45. PubMed ID: 18300227
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite.
Savvides SN; Scheiwein M; Bohme CC; Arteel GE; Karplus PA; Becker K; Schirmer RH
J Biol Chem; 2002 Jan; 277(4):2779-84. PubMed ID: 11705998
[TBL] [Abstract][Full Text] [Related]
36. Catalytic cycle of human glutathione reductase near 1 A resolution.
Berkholz DS; Faber HR; Savvides SN; Karplus PA
J Mol Biol; 2008 Oct; 382(2):371-84. PubMed ID: 18638483
[TBL] [Abstract][Full Text] [Related]
37. Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.
Gallo V; Schwarzer E; Rahlfs S; Schirmer RH; van Zwieten R; Roos D; Arese P; Becker K
PLoS One; 2009 Oct; 4(10):e7303. PubMed ID: 19806191
[TBL] [Abstract][Full Text] [Related]
38. Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on
Marozienė A; Lesanavičius M; Davioud-Charvet E; Aliverti A; Grellier P; Šarlauskas J; Čėnas N
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835450
[TBL] [Abstract][Full Text] [Related]
39. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target.
Harwaldt P; Rahlfs S; Becker K
Biol Chem; 2002 May; 383(5):821-30. PubMed ID: 12108547
[TBL] [Abstract][Full Text] [Related]
40. The putative gamma-glutamylcysteine synthetase from Plasmodium falciparum contains large insertions and a variable tandem repeat.
Lüersen K; Walter RD; Müller S
Mol Biochem Parasitol; 1999 Jan; 98(1):131-42. PubMed ID: 10029315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
